Telehealth and remote blood pressure management for pregnant women with chronic high blood pressure
Official title: Feasibility and Safety of Incorporating Telehealth Visits Combined With Remote Blood Pressure Monitoring in the Management of Chronic Hypertension in Pregnancy
Run by Wake Forest University Health Sciences · NCT07356518 · Data updated 2026-11-12
This study tests whether alternating telehealth visits with home blood pressure monitoring and health coaching helps pregnant women (18–45) with chronic high blood pressure compared with standard in-person care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | April 22, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | April 27, 2026 |
| Trial ID | NCT07356518 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women aged 18–45 with a documented diagnosis of chronic hypertension or on antihypertensive medication before pregnancy who receive prenatal care and plan to deliver at Atrium Health Wake Forest Baptist.
✕Probably not a fit
Patients with severe hypertension, significant cardiac disorders, multifetal pregnancy, current substance abuse, prior stroke, major fetal abnormalities, or those planning to deliver outside the study hospital are excluded and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Pregnant women with chronic hypertension are assigned to either alternating telehealth visits with remote blood pressure monitoring plus five health coaching sessions or to standard in-person clinic visits. Telehealth participants alternate telehealth and clinic visits every two weeks until pregnancy week 31 and receive five phone or video coaching sessions through week 36, while the control group follows usual in-person care. The study focuses on feasibility outcomes (willingness to enroll, completion rate, adherence to monitoring) and also explores safety outcomes related to blood pressure control and pregnancy complications through delivery. Participation continues until the baby is delivered and requires the ability to use telehealth technology and plan to deliver at the study hospital.
Why it matters
Potential benefit: If successful, this approach could reduce in-person visit burden, improve home blood pressure monitoring and medication adherence, and potentially lower hypertension-related admissions during pregnancy.
How similar studies have gone: Some prior digital blood pressure management programs in high-risk pregnancies showed fewer hypertension-related admissions, but evidence specifically for chronic hypertension in pregnancy is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * prior diagnosis of Chronic hypertension (cHTN) * Pregnant women * Known: documented diagnosis or on antihypertensive medication prior to pregnancy Exclusion Criteria: * Any significant chronic medical or psychiatric illness that, in the investigator's opinion, would prevent participation in the study * Cardiac disorders: cardiomyopathy, angina, Coronary Artery Disease (CAD) * Current substance abuse disorder * Multifetal pregnancy * Participation in another study without prior approval * Plan to deliver outside Atrium Health Wake Forest Baptist * Prior stroke * Severe hypertension * Suspected or known fetal major structural/chromosomal abnormality or fetal demise
Where it's running
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Aderonke O Adeniyi, MD, MS — Wake Forest University Health Sciences
- Study coordinator: Ejiro Obioma, MBBS MMCi
- Email: Ejiro.Obioma@Advocatehealth.org
- Phone: 704-355-2000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Measuring Blood Pressure in Pregnant Women Using Different Cuffs
This study is testing if a special forearm cuff gives more accurate blood pressure readings for pregnant women compared to a regular upper arm cuff, especially for those who are very overweight.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Using inorganic nitrate to treat high blood pressure in pregnant women
This study is testing if taking inorganic nitrate can help pregnant women with high blood pressure improve their blood pressure and support their baby's health.
-
Understanding cardiovascular risks in young adults born to hypertensive pregnancies
This study is looking at the heart health of young adults in their 20s and 30s who were born to mothers with high blood pressure during pregnancy to see if it affects their risk of heart problems later on.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.